After receiving the Second Moderna Covid-19 vaccine, got a stomach ulcer; Received First dose on the 7Feb2022 and Second dose on the 15Mar2022; This spontaneous case was reported by a consumer and describes the occurrence of GASTRIC ULCER (After receiving the Second Moderna Covid-19 vaccine, got a stomach ulcer) in a 30-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in July 2021. Concurrent medical conditions included Blood pressure high (has high blood pressure since patient was born) since 1991 and Hypersensitivity (Sensitive to everything.). Concomitant products included AMLODIPINE for Blood pressure high, MACA [LEPIDIUM MEYENII] for Herbal supplement.   On 07-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 15-Mar-2022, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received First dose on the 7Feb2022 and Second dose on the 15Mar2022). On 15-Mar-2022, the patient experienced GASTRIC ULCER (After receiving the Second Moderna Covid-19 vaccine, got a stomach ulcer) (seriousness criterion medically significant). At the time of the report, GASTRIC ULCER (After receiving the Second Moderna Covid-19 vaccine, got a stomach ulcer) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received First dose on the 7Feb2022 and Second dose on the 15Mar2022) outcome was unknown.            Additionally it was stated that, patient had to always take the lowest doses of medications or she would get the worst side effect. She did not received any other vaccine within one month prior to Moderna's. It was reported that, she had no similar event in the past.  The treatment information was reported as some unknown Ulcer antibodies for stomach ulcer.  Company Comment: This is a spontaneous case reported by a consumer, concerning a 30-year-old female patient with no relevant medical history, who experienced the unexpected, serious (medically significant) event of Gastric ulcer, on the same day after receiving the second dose of mRNA-1273 vaccine. It should be noted that the two primary doses of mRNA-1273 were administered at an interval of 36 days. Inappropriate schedule of product administration was noted. Patient did not receive any other vaccine within one month prior to Moderna's. Patient had no similar events in the past. Treatment information was reported as some unknown Ulcer antibodies for stomach ulcer. The event had not resolved. The benefit-risk relationship of mRNA-1273 is not affected by this report. Event seriousness assessed as an Important medical event per medical judgement.   This case was linked to MOD-2022-533231 (Patient Link).; Sender's Comments: This is a spontaneous case reported by a consumer, concerning a 30-year-old female patient with no relevant medical history, who experienced the unexpected, serious (medically significant) event of Gastric ulcer, on the same day after receiving the second dose of mRNA-1273 vaccine. It should be noted that the two primary doses of mRNA-1273 were administered at an interval of 36 days. Inappropriate schedule of product administration was noted. Patient did not receive any other vaccine within one month prior to Moderna's. Patient had no similar events in the past. Treatment information was reported as some unknown Ulcer antibodies for stomach ulcer. The event had not resolved. The benefit-risk relationship of mRNA-1273 is not affected by this report. Event seriousness assessed as an Important medical event per medical judgement.